New Measures Tighten Quality Checks on Ayurvedic Medicines
In a parliamentary session, the Ayush Minister outlined a series of steps to raise the bar on product quality for traditional medicines. Under the Drugs and Cosmetics Act, 1940 and the 1945 Rules, manufacturers of Ayurvedic, Siddha, Unani and Homeopathic drugs must secure a licence that confirms adherence to manufacturing norms before any product reaches the market.
Drug inspectors from state and union territory authorities now conduct routine sampling at factories and retail shops. Collected specimens are dispatched to accredited labs for physicochemical and microbiological testing. When a sample falls short of the prescribed limits, regulators initiate prosecution under the Act.
A dedicated Ayush vertical within the Central Drugs Standard Control Organization has been created to centralise oversight. Additionally, the Quality Council of India’s third‑party certification programme awards "Ayush Standard" and "Ayush Premium" seals after rigorous assessment, helping consumers identify trustworthy products.
The ministry’s "Ayush Medicine Quality and Production Enhancement Scheme" also seeks to improve standardisation, boost testing capacity, and enforce stricter control over digital advertising. Online sellers are now required to verify a valid prescription before enabling the sale of certain Ayush medicines, curbing the spread of unverified health claims.